Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
NCT03272269
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
IMCY-0098
OTHER:
Placebo
Sponsor
Imcyse SA